256 related articles for article (PubMed ID: 12076241)
1. Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.
Civitelli R; Pilgram TK; Dotson M; Muckerman J; Lewandowski N; Armamento-Villareal R; Yokoyama-Crothers N; Kardaris EE; Hauser J; Cohen S; Hildebolt CF
Arch Intern Med; 2002 Jun; 162(12):1409-15. PubMed ID: 12076241
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
3. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
[TBL] [Abstract][Full Text] [Related]
4. The pattern of alveolar crest height change in healthy postmenopausal women after 3 years of hormone/estrogen replacement therapy.
Hildebolt CF; Pilgram TK; Yokoyama-Crothers N; Vannier MW; Dotson M; Muckerman J; Armamento-Villareal R; Hauser J; Cohen S; Kardaris EE; Hanes P; Shrout MK; Civitelli R
J Periodontol; 2002 Nov; 73(11):1279-84. PubMed ID: 12479631
[TBL] [Abstract][Full Text] [Related]
5. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.
Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR
Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459
[TBL] [Abstract][Full Text] [Related]
6. A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.
Thiébaud D; Bigler JM; Renteria S; Pache T; Welti HJ; Landry M; Burckhardt P
Climacteric; 1998 Sep; 1(3):202-10. PubMed ID: 11907945
[TBL] [Abstract][Full Text] [Related]
7. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
Greenspan SL; Emkey RD; Bone HG; Weiss SR; Bell NH; Downs RW; McKeever C; Miller SS; Davidson M; Bolognese MA; Mulloy AL; Heyden N; Wu M; Kaur A; Lombardi A
Ann Intern Med; 2002 Dec; 137(11):875-83. PubMed ID: 12458987
[TBL] [Abstract][Full Text] [Related]
8. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.
Greenspan SL; Resnick NM; Parker RA
JAMA; 2003 May; 289(19):2525-33. PubMed ID: 12759324
[TBL] [Abstract][Full Text] [Related]
10. The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur.
Duan Y; Tabensky A; DeLuca V; Seeman E
Bone; 1997 Nov; 21(5):447-51. PubMed ID: 9356739
[TBL] [Abstract][Full Text] [Related]
11. The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Bhattoa HP; Bettembuk P; Balogh A; Szegedi G; Kiss E
Osteoporos Int; 2004 May; 15(5):396-404. PubMed ID: 14676992
[TBL] [Abstract][Full Text] [Related]
12. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
Gallagher JC; Kable WT; Goldgar D
Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
[TBL] [Abstract][Full Text] [Related]
13. Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys.
Jayo MJ; Register TC; Carlson CS
Bone; 1998 Oct; 23(4):361-6. PubMed ID: 9763148
[TBL] [Abstract][Full Text] [Related]
14. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
Cundy T; Ames R; Horne A; Clearwater J; Roberts H; Gamble G; Reid IR
J Clin Endocrinol Metab; 2003 Jan; 88(1):78-81. PubMed ID: 12519833
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial.
Villareal DT; Binder EF; Williams DB; Schechtman KB; Yarasheski KE; Kohrt WM
JAMA; 2001 Aug; 286(7):815-20. PubMed ID: 11497535
[TBL] [Abstract][Full Text] [Related]
17. Rates of bone loss in peri- and postmenopausal women: a 4 year, prospective, population-based study.
Young R; May H; Murphy S; Grey C; Compston JE
Clin Sci (Lond); 1996 Sep; 91(3):307-12. PubMed ID: 8869413
[TBL] [Abstract][Full Text] [Related]
18. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.
Grey AB; Cundy TF; Reid IR
Clin Endocrinol (Oxf); 1994 May; 40(5):671-7. PubMed ID: 8013147
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
Gutteridge DH; Holzherr ML; Retallack RW; Price RI; Will RK; Dhaliwal SS; Faulkner DL; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Drury PJ; Tran L; Bhagat CI; Kent GN; Jamrozik K
Calcif Tissue Int; 2003 Jul; 73(1):33-43. PubMed ID: 14506952
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
